Rochester Clinical Research is currently seeking participants 50 years or older for a phase 3 Type 2 Diabetes Mellitus (T2DM) research study. The study is approximately 34 weeks long and 9 visits to the office. Compensation will be available for trial-related time if you qualify to participate.
Type 2 diabetes mellitus is a chronic condition that affects the way your body processes blood sugar (glucose). It occurs when the body becomes resistant to insulin or doesn’t produce enough insulin to maintain normal blood sugar levels. Common symptoms include increased thirst, frequent urination, fatigue, and slow healing of wounds. Over time, unmanaged type 2 diabetes can lead to serious complications like heart disease, nerve damage, kidney issues, and vision problems. While there is no cure, the condition can be managed through lifestyle changes, medications, and regular monitoring of blood sugar levels.
The purpose of this study is to compare how well three doses of the investigational product work versus a placebo in improving blood sugar control (A1C levels) in people with poorly controlled type 2 diabetes who are on 1-3 glucose-lowering medications.
Qualifications:
– 50 years or older
– Established diagnosis of T2DM for at least 6 months
– On a stable dose of at least one and up to three of the following glucose-lowering agents: Metformin, sulfonylurea, DPP-4 inhibitor, SGLT-2 inhibitor, thiazolidinedione, insulin secretagogue, oral or injected GLP-1 receptor agonists, glucosidase inhibitor, or pramlintide (injected insulin is excluded) for a minimum of 3 months
– No history of Type 1 Diabetes
– No treatment involving injected insulin within the last 3 months
– *Please note, other qualifications apply
Rochester Clinical Research is currently seeking participants between the ages of 18-85 years old for an Avian Flu vaccine research […]
Rochester Clinical Research is currently seeking participants who may be interested in participating in a yellow fever vaccine study that […]
Rochester Clinical Research is currently seeking participants 50 years or older for a phase 3 Type 2 Diabetes Mellitus (T2DM) […]
Rochester Clinical Research is looking for participants interested in upcoming obesity studies. While full details aren’t available yet, you can […]
Rochester Clinical Research is currently seeking healthy volunteers between the ages of 18-30 years old to participate in an mRNA […]
Rochester Clinical Research is currently seeking volunteers between the ages of 9-15 years old to participate in a study to […]
© 2024 Rochester Clinical Research
